In silico drug repurposing for the treatment of heart diseases using gene expression data and molecular docking techniques

被引：7

作者：

Aalikhani, Mahdi ^{[1
]}

Alikhani, Mehrdad ^{[2
]}

Shamsabadi, Fatemeh ^{[1
,3
]}

Oladnabi, Morteza ^{[4
,5
,6
]}

Bazi, Zahra ^{[1
,5
]}

机构：

[1] Golestan Univ Med Sci, Sch Adv Technol Med, Dept Med Biotechnol, Gorgan, Golestan, Iran

[2] Shahid Beheshti Univ Med Sci, Masih Daneshvari Hosp, Dept Cardiol, Tehran, Iran

[3] Golestan Univ Med Sci, Med Cellular & Mol Res Ctr, Gorgan, Golestan, Iran

[4] Golestan Univ Med Sci, Canc Res Ctr, Gorgan, Golestan, Iran

[5] Golestan Univ Med Sci, Stem Cell Res Ctr, Gorgan, Golestan, Iran

[6] Golestan Univ Med Sci, Ischem Disorders Res Ctr, Gorgan, Golestan, Iran

来源：

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 2021年 / 572卷

关键词：

Drug discovery; Drug repurposing; Heart diseases; Molecular docking; RNA sequencing; DISCOVERY;

D O I：

10.1016/j.bbrc.2021.07.076

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Heart diseases are known as the most primary causes of mortality worldwide. Although many therapeutic approaches and medications are proposed for these diseases, the identification of novel therapeutics in fatal heart conditions is promptly demanded. Besides, the interplay between gene expression data and molecular docking provides several novel insights to discover more effective and specific drugs for the treatment of the diseases. This study aimed to discover potent therapeutic drugs in the heart diseases based on the expression profile of heart-specific genes exclusively. Initially, the heart-specific and highly expressed genes were identified by comparing the gene expression profile of different body tissues. Subsequently, the druggable-genes were identified using in silico techniques. The interaction between these druggable genes with more than 1600 FDA approved drugs was then investigated using the molecular docking simulation. By comprehensively analyzing RNA-sequencing data obtained from 949 normal tissue samples, 48 heart-specific genes were identified in both the heart development and function. Notably, of these, 24 heart-specific genes were capable to be considered as druggable genes, among which only MYBPC3, MYLK3, and SCN5A genes entered the molecular docking process due to their functions. Afterward, the pharmacokinetics properties of top 10 ligands with the highest binding affinity for these proteins were studied. Accordingly, methylergonovine, fosaprepitant, pralatrexate, daunorubicin, glecaprevir, digoxin, and venetoclax drugs were competent, in order to interact with the target proteins perfectly. It was shown that these medications can be used as specific drugs for the treatment of heart diseases after fulfilling further experiments in this regard. (c) 2021 Elsevier Inc. All rights reserved.

引用

页码：138 / 144

页数：7

共 50 条

[21] Potential target identification for osteosarcoma treatment: Gene expression re-analysis and drug repurposing [J].

Kamolphiwong, Rawikant ;

Kanokwiroon, Kanyanatt ;

Wongrin, Weerinrada ;

Chaiyawat, Parunya ;

Klangjorhor, Jeerawan ;

Settakorn, Jongkolnee ;

Teeyakasem, Pimpisa ;

Sangphukieo, Apiwat ;

Pruksakorn, Dumnoensun .

GENE, 2023, 856

[22] In Silico Analysis of Pyeongwi-San Involved in Inflammatory Bowel Disease Treatment Using Network Pharmacology, Molecular Docking, and Molecular Dynamics [J].

Bae, Chang-Hwan ;

Kim, Hee-Young ;

Seo, Ji Eun ;

Lee, Hanul ;

Kim, Seungtae .

BIOMOLECULES, 2023, 13 (09)

[23] Repurposing haloperidol for the treatment of rheumatoid arthritis: an integrative approach using data mining techniques [J].

Nakagawa, Chihiro ;

Yokoyama, Satoshi ;

Hosomi, Kouichi ;

Takada, Mitsutaka .

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2021, 13

[24] DNA binding studies of antibiotic drug cephalexin using spectroscopic and molecular docking techniques [J].

Shahabadi, Nahid ;

Hashempour, Shokoufeh .

NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2019, 38 (06) :428-447

[25] Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target [J].

Arun, K. G. ;

Sharanya, C. S. ;

Abhithaj, J. ;

Francis, Dileep ;

Sadasivan, C. .

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (13) :4647-4658

[26] Repurposing of clinically proven bioactive compounds for targeted treatment of Alzheimer’s disease using molecular docking approach [J].

Thasma Loganath Babu Vasanth Kanth ;

Archi Raha ;

R M Vijay Murali ;

Natesan Yuvatha ;

Kasinathan Kumaran ;

Rangasamy Kirubakaran ;

KN ArulJothi .

In Silico Pharmacology, 11 (1)

[27] In Silico Antiprotozoal Evaluation of 1,4-Naphthoquinone Derivatives against Chagas and Leishmaniasis Diseases Using QSAR, Molecular Docking, and ADME Approaches [J].

Prieto Cardenas, Lina S. ;

Arias Soler, Karen A. ;

Nossa Gonzalez, Diana L. ;

Rozo Nunez, Wilson E. ;

Cardenas-Chaparro, Agobardo ;

Duchowicz, Pablo R. ;

Gomez Castano, Jovanny A. .

PHARMACEUTICALS, 2022, 15 (06)

[28] Study on the interaction of the drug mesalamine with calf thymus DNA using molecular docking and spectroscopic techniques [J].

Shahabadi, Nahid ;

Fili, Soraya Moradi ;

Kheirdoosh, Fahimeh .

JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2013, 128 :20-26

[29] Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics [J].

Mohammed, Ahmed O. ;

Abo-Idrees, Mazin I. ;

Makki, Alaa A. ;

Ibraheem, Walaa ;

Alzain, Abdulrahim A. .

STRUCTURAL CHEMISTRY, 2022, 33 (05) :1553-1567

[30] Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics [J].

Ahmed O. Mohammed ;

Mazin I. Abo-Idrees ;

Alaa A. Makki ;

Walaa Ibraheem ;

Abdulrahim A. Alzain .

Structural Chemistry, 2022, 33 :1553-1567

← 1 2 3 4 5 →